PhilArchive
open access
Ethical qualms about genetic prognosis
The debate about direct-to-consumer genetic testing has centred on whether consumers are the best judges of their own clinical care. Inthis article, I also examine whether the science of personalized medicine is really as advanced as its proponents claim, and how the availability of genetic markers affects decisions on who gets and does not get medical treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Consumer Genetic Technologies: Ethical and Legal Considerations#467900
- Genetic Discrimination in Health Insurance: An Ethical and Economic Analysis#112505
- Genetic Testing, Privacy, and the Law: Addressing Gaps in Legal Protections for Patients and Donors#1177429
- Genetic Testing, Privacy, and the Law: Addressing Gaps in Legal Protections for Patients and Donors#1177390
- Genetic privacy: a challenge to medico-legal norms: G Laurie. Cambridge University Press, 2002, 50.00 (hbk), pp 335. ISBN 0521660270#718540
Record · ID 720184
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive